| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
REPRODUCTION-DEVELOPMENT |
Department of Anatomy (Y.I.), Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki 305-8575, Japan; Comprehensive Reproductive Medicine (A.N.) and Section of Molecular Embryology (A.N., M.-a.I.), Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan; and Graduate School of Integrated Science (S.H.), Yokohama City University, Yokohama 236-0027, Japan
Address all correspondence and requests for reprints to: Yayoi Ikeda, D.D.S., Ph.D., Department of Anatomy, Institute of Basic Medical Sciences, University of Tsukuba, 1-1-1 Tennohdai, Tsukuba, Ibaraki 305-8575, Japan. E-mail: yayoi-ik{at}md.tsukuba.ac.jp
Müllerian-inhibiting substance (MIS) is an essential factor for male sexual differentiation. In the present study, we examined whether the expression of MIS and several of its related transcription factors is altered in the ovaries of rats treated with the synthetic estrogen, E2 benzoate (EB; 10 µg/0.02 ml), from postnatal day 1 (P1) to P5. The EB-treated rats had a significantly reduced number of layered follicles at P6 in comparison with the control rats that were treated with vehicle alone. The expression levels of both MIS mRNA and protein in the granulosa cells of small growing follicles in the ovary at P6 were higher in the EB-treated rats than in the controls. These results indicate that the inhibitory effect of EB on the follicular stratification may correlate with the inappropriately increased expression level of MIS. Furthermore, the expression levels of one of its transcriptional activators, steroidogenic factor 1, and ER-ß in granulosa cells of small growing follicles were higher in EB-treated ovaries than in the control ovaries. These results suggest the role of MIS in the regulation of follicular growth and the possible involvement of steroidogenic factor 1and/or ER-ß in this molecular cascade may contribute to postnatal ovarian development.
This article has been cited by other articles:
![]() |
E. Nilsson, G. Dole, and M. K Skinner Neurotrophin NT3 promotes ovarian primordial to primary follicle transition Reproduction, October 1, 2009; 138(4): 697 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, H. Tanaka, and M. Esaki Effects of Gestational Diethylstilbestrol Treatment on Male and Female Gonads during Early Embryonic Development Endocrinology, August 1, 2008; 149(8): 3970 - 3979. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dole, E. E Nilsson, and M. K Skinner Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis Reproduction, May 1, 2008; 135(5): 671 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W Kabithe and N. J Place Photoperiod-dependent modulation of anti-Mullerian hormone in female Siberian hamsters, Phodopus sungorus Reproduction, March 1, 2008; 135(3): 335 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.A Johnson, T.R Kent, M.E Urick, and J.R Giles Expression and Regulation of Anti-Mullerian Hormone in an Oviparous Species, the Hen Biol Reprod, January 1, 2008; 78(1): 13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nilsson, N. Rogers, and M. K Skinner Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition Reproduction, August 1, 2007; 134(2): 209 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Marca and A. Volpe The Anti-Mullerian hormone and ovarian cancer Hum. Reprod. Update, May 1, 2007; 13(3): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uzumcu, P. E Kuhn, J. E Marano, A. E Armenti, and L. Passantino Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary J. Endocrinol., December 1, 2006; 191(3): 549 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-Mullerian hormone throughout the human menstrual cycle Hum. Reprod., December 1, 2006; 21(12): 3103 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Kezele, J. M. Ague, E. Nilsson, and M. K. Skinner Alterations in the Ovarian Transcriptome During Primordial Follicle Assembly and Development Biol Reprod, January 1, 2005; 72(1): 241 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kezele and M. K. Skinner Regulation of Ovarian Primordial Follicle Assembly and Development by Estrogen and Progesterone: Endocrine Model of Follicle Assembly Endocrinology, August 1, 2003; 144(8): 3329 - 3337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misra, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee The Role of Mullerian Inhibiting Substance in the Evaluation of Phenotypic Female Patients with Mild Degrees of Virilization J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. Jefferson, J. F. Couse, E. Padilla-Banks, K. S. Korach, and R. R. Newbold Neonatal Exposure to Genistein Induces Estrogen Receptor (ER){alpha} Expression and Multioocyte Follicles in the Maturing Mouse Ovary: Evidence for ER{beta}-Mediated and Nonestrogenic Actions Biol Reprod, October 1, 2002; 67(4): 1285 - 1296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |